secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0000950170-24-087947
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 2.05, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON Pharmaceuticals to wind down operations, terminate employees, seek dissolution
--------------------------------------------------------------------------------

- Board approves reduction-in-force of substantially all employees effective July 31, 2024; expects ~$1.7M in severance costs.
- Board approves Plan of Dissolution and liquidation, subject to stockholder vote at a special meeting.
- All directors resign; CEO Charles Theuer and CFO Scott Brown depart on July 31, 2024.
- Appoints Craig R. Jalbert as President, CEO, Secretary, Treasurer, and sole Board member to oversee wind-down.
- Jalbert, a distressed-business specialist, will receive $10K/month until dissolution vote, then $50K/year for 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024087947/0000950170-24-087947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024087947/tcon-20240726.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-087947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer